Immunobiology of head and neck cancer: Basic concepts
- 1 September 1979
- journal article
- review article
- Published by Wiley in Head & Neck Surgery
- Vol. 2 (1) , 42-55
- https://doi.org/10.1002/hed.2890020107
Abstract
Patients with squamous cancer of the head and neck have unique perturbations of the immune system. These patients have marked depression of cellular immunity even in the early stages of disease. The known facts about the immunobiology and the immunodeficiencies that commonly occur are discussed. Also reviewed are the relationships of the immunologic deficits to stage of disease, to prognosis, and to the suspected etiologic factors of smoking, alcoholism, and malnutrition. Highlights are given of current immunotherapeutic trials. To date, most of the successful efforts in both immunobiologic research and immunotherapy of head and neck cancer have dealt with general, rather than specific, immune reactions. Future development in the area of specific immune responses may permit more meaningful measurements of tumor‐specific reactions, thus yielding useful tools for immunodiagnosis as well as providing more effective and precise methods of immunotherapy.Keywords
This publication has 81 references indexed in Scilit:
- The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tractJournal of Surgical Oncology, 1978
- Spontaneous rosette formation and rosette inhibition assays in patients with squamous cell carcinoma of the head and neckCancer, 1977
- Epstein-barr virus antibodies in tonsillar carcinoma patientsInternational Journal of Cancer, 1977
- Adjuvant chemoimmunotherapy in advanced lesions of the head and neckAmerican Journal of Roentgenology, 1976
- Cell-mediated immune response in head and neck cancer patientsJournal of Surgical Oncology, 1976
- Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseasesClinical Immunology and Immunopathology, 1976
- The association of the IgA levels of serum and whole saliva with the progression of oral cancerCancer, 1975
- Thymus-derived lymphocytes in patients with solid malignanciesClinical Immunology and Immunopathology, 1975
- Suppression of the tuberculin response in malignant disease.BMJ, 1965
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964